Pharmaceutical/Dietary Supplements/Medical Devices

Evaluate nonclinical data for Investigational Device Exemptions (IDE).

Conduct pre-study audits of toxicology and bioanalytical testing facilities to ensure compliance for Sponsor studies.

Quality assurance review of study design to ensure compliance with FDA Quality System (QS) regulations.

Evaluate the safety of dietary supplements.

Literature review and analysis of toxicology and pharmacokinetic studies to develop occupational exposure limits (OEL).

Corporate Headquarters
1367 Connecticut Avenue NW,
Suite 300
Washington, DC 20036
Telephone: 202-429-8787
Fax: 202-429-8788

Follow us on facebook.